Claire McDonough, the Chief Financial Officer of $RIVN, sold 7,247 shares of the company on 08-18-2025 for an estimated $88,993. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.9% of their shares of this class of stock. Following this trade, they now own 789,445 shares of this class of $RIVN stock.
$RIVN Insider Trading Activity
$RIVN insiders have traded $RIVN stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $RIVN stock by insiders over the last 6 months:
- ROBERT J SCARINGE (Chief Executive Officer) has made 0 purchases and 5 sales selling 357,143 shares for an estimated $4,788,250.
- CLAIRE MCDONOUGH (Chief Financial Officer) has made 0 purchases and 5 sales selling 41,225 shares for an estimated $600,284.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RIVN Hedge Fund Activity
We have seen 322 institutional investors add shares of $RIVN stock to their portfolio, and 371 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TWO SIGMA ADVISERS, LP added 12,730,800 shares (+532.9%) to their portfolio in Q2 2025, for an estimated $174,921,192
- TWO SIGMA INVESTMENTS, LP added 11,833,167 shares (+461.2%) to their portfolio in Q2 2025, for an estimated $162,587,714
- UBS GROUP AG removed 10,135,326 shares (-34.8%) from their portfolio in Q2 2025, for an estimated $139,259,379
- GOLDMAN SACHS GROUP INC removed 7,537,636 shares (-64.3%) from their portfolio in Q2 2025, for an estimated $103,567,118
- BANK OF AMERICA CORP /DE/ added 7,076,714 shares (+66.1%) to their portfolio in Q2 2025, for an estimated $97,234,050
- MORGAN STANLEY removed 5,079,695 shares (-29.9%) from their portfolio in Q2 2025, for an estimated $69,795,009
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,774,287 shares (-19.0%) from their portfolio in Q2 2025, for an estimated $51,858,703
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RIVN Analyst Ratings
Wall Street analysts have issued reports on $RIVN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 08/08/2025
- Needham issued a "Buy" rating on 08/06/2025
- Wedbush issued a "Outperform" rating on 08/06/2025
- JP Morgan issued a "Underweight" rating on 08/06/2025
- Benchmark issued a "Buy" rating on 03/18/2025
- B of A Securities issued a "Underperform" rating on 02/24/2025
To track analyst ratings and price targets for $RIVN, check out Quiver Quantitative's $RIVN forecast page.
$RIVN Price Targets
Multiple analysts have issued price targets for $RIVN recently. We have seen 17 analysts offer price targets for $RIVN in the last 6 months, with a median target of $14.0.
Here are some recent targets:
- Adam Jonas from Morgan Stanley set a target price of $12.0 on 08/13/2025
- Stephen Gengaro from Stifel set a target price of $16.0 on 08/08/2025
- Joseph Spak from UBS set a target price of $12.0 on 08/06/2025
- Ryan Brinkman from JP Morgan set a target price of $9.0 on 08/06/2025
- George Gianarikas from Canaccord Genuity set a target price of $21.0 on 08/06/2025
- Daniel Ives from Wedbush set a target price of $16.0 on 08/06/2025
- Chris Pierce from Needham set a target price of $14.0 on 08/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
